Update shared on 06 Dec 2025
Narrative Update on Quaker Chemical
Analysts have maintained their price target for Quaker Chemical at approximately 166 dollars, as modest adjustments to the discount rate and long term growth assumptions were not deemed sufficient to warrant a change in fair value.
What's in the News
- The company completed its share repurchase program announced on February 28, 2024, buying back a total of 638,901 shares, or about 3.59% of shares outstanding, for approximately 85.75 million dollars (company filing).
- In the most recent tranche, from July 1, 2025, to September 30, 2025, the company repurchased 29,791 shares, representing roughly 0.17% of shares, for about 3.81 million dollars (company filing).
Valuation Changes
- Fair Value: Unchanged at approximately $166 per share, indicating that minor input adjustments did not affect the overall valuation outcome.
- Discount Rate: Fallen slightly from about 8.14% to 8.08%, reflecting a modest reduction in the assumed risk or required return.
- Revenue Growth: Essentially unchanged, remaining at roughly 4.0% per year, suggesting no material shift in top line growth expectations.
- Net Profit Margin: Stable at around 15.3%, with only immaterial rounding differences, implying consistent expectations for long term profitability.
- Future P/E: Edged down slightly from about 10.46x to 10.44x, a negligible change that leaves valuation multiples broadly intact.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.